UBS Group
MDLA

UBS Group’s Medallia, Inc. MDLA Stock Holding History

UBS Group’s Portfolio MDLA Stock Details MDLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-685
Closed -$23K – 11363
2021
Q3 		$23K Sell
685
-106,203
-99% -$3.55M ﹤0.01% 7047
2021
Q2 		$3.61M Buy
106,888
+97,969
+1,098% +$2.82M ﹤0.01% 3014
2021
Q1 		$248K Buy
8,919
+2,369
+36% +$87.9K ﹤0.01% 5333
2020
Q4 		$218K Sell
6,550
-26,064
-80% -$831K ﹤0.01% 5192
2020
Q3 		$894K Buy
32,614
+13,554
+71% +$411K ﹤0.01% 3722
2020
Q2 		$481K Buy
19,060
+7,819
+70% +$187K ﹤0.01% 4172
2020
Q1 		$226K Buy
11,241
+10,459
+1,337% +$281K ﹤0.01% 4628
2019
Q4 		$24K Buy
782
+174
+29% +$5.14K ﹤0.01% 6775
2019
Q3 		$17K Buy
+608
New +$21.6K ﹤0.01% 6845

UBS Group's MDLA Position: Q4 2021 in Review

UBS Group sold out of Medallia, Inc. (MDLA) in Q4 2021, closing a stake of 685 shares — an estimated $23K sold.

UBS Group first reported a position in MDLA in Q3 2019 and held it in 9 quarters. The position peaked at $3.61M in Q2 2021. 0 funds tracked by Wall St. Rank hold MDLA as of Q4 2021.

  • UBS Group reported no remaining Medallia, Inc. position as of Q4 2021 after selling out during the quarter.
  • UBS Group sold 685 Medallia, Inc. shares in Q4 2021, an estimated $23K.
  • UBS Group first reported a position in Medallia, Inc. in Q3 2019 and held it in 9 quarters.
  • UBS Group's Medallia, Inc. position peaked at $3.61M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Medallia, Inc. as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.